“…Swerdlow and Koob, 1987). However, it is also critical to note that PPI (and presumably its underlying neural
regulation) appears to remain relatively intact, or at least functional, in a number
of other serious brain disorders, including attention deficit disorder (ADHD; Castellanos et al, 1996; Conzelmann et al, 2010; Feifel et al, 2009; Hanlon et al,
2012; Ornitz et al, 1992, 1999), high functioning autism (Kohl et al 2014), bipolar disorder (in euthymic states;
Barrett et al, 2005; Carroll et al, 2007; but see Sanchez-Morla et al, 2016), and major depressive
disorder (Ludewig and Ludewig, 2003; Perry et al, 2004; Quednow et al, 2006), while evidence from chronic
substance use disorders is mixed and likely to be substance specific (e.g. Quednow et al, 2004; Schellekens et al, 2012).…”